Patient reported outcomes interfering with daily activities in prostate cancer patients receiving antineoplastic treatment.
Dag Rune StormoenChristina BaekstedGry Assam TaarnhøjChristoffer JohansenHelle PappotPublished in: Acta oncologica (Stockholm, Sweden) (2021)
PRO may help inform caregivers about symptoms not previously reported, interfering with usual or daily activities but also point to the use of this information to inform new patients. This may help clinicians and patients decide a treatment plan with an acceptable benefit-to-harm ratio.